-
-
The FDA has approved a non-halogenated nasal steroid for use in pediatric patients aged 6 to 12 years and adults. Ciclesonide is a prodrug that was previously approved for adults and adolescents but was not marketed. It's to be marketed by Nycomed US Inc. as Omnaris.
-
Serum analysis of 45 subjects for antibodies and humoral immunity over a median of 15 years showed antiviral responses ranging from 11-19 years for tetanus-diphtheria, 50 years for varicella-zoster, and up to 200 years for measles and mumps.
-
FDA warnings for existing drugs dominate pharmaceutical news this month.
-
12-lead ECG obtained from a 50-year old African American man with hypertension and chest pain.
-
-
When whole grain cereal (WGC) is consumed regularly, there is a lower risk of developing heart failure (HF). This association is likely to be linked to the beneficial effects of WGC on risk factors (ie, hypertension, obesity, hyperlipidemia) rather than HF itself.
-
An elevated white blood cell count is a risk factor for several cancers in women.
-
Two hundred eighty-eight patients hospitalized with severe community-acquired pneumonia (CAP) were followed for 28 days in a prospective multicenter study.
-
Weight gain has long been used as a marker of fluid retention in heart failure patients. It is a cheap, simple test that can be performed daily in patients' homes.